Fat Grafting Results Improved with Brava Device at Changes Plastic Surgery

by

Fat Grafting Results Improved with Brava Device at Changes Plastic Surgery


Gilbert Lee, M.D., FACS at Changes Plastic Surgery in San Diego, California routinely performs breast reconstruction with augmentation using fat grafting technique. Dr. Lee finds the use of the Brava medical device a vital component of a successful breast augmentation by fat transfer.  A recent clinical study featured in the May 2012 issue of Plastic & Reconstructive Surgery supports Dr. Lee’s experience with this device.

Background:  The Brava Breast Enhancement and Shaping System increases and reshapes breast tissue through a process known as tissue expansion.  Worn at night, the Brava device applies gentle, sustained tension on the breast(s), which causes cells to replicate and produce new breast tissue. Dr. Lee recommends the Brava device to his patients who have too little breast tissue to allow for significant augmentation through the fat grafting technique.


With first-hand clinical experience, Dr. Gilbert Lee sees the use of the Brava device as the best way to enhance the success of fat transfers to the breast. It upgrades the vascularity of the recipient site and allows a larger volume of fat to be grafted. The Brava is used prior to the main fat transfer. Supporting Dr. Lee’s case experience, a recent 81-patient multi-center study of the use of the Brava device concludes the same.


*Methods: In a prospective multicenter study, 81 women (age range, 17 to 63 years) wore the Brava device, a bra-like vacuum-based external tissue expander, for 4 weeks and then underwent autologous fat injection using 10 to 14 needle puncture sites into each breast in a three-dimensional fanning pattern (average, 277 ml volume injected per breast). Patients resumed Brava wear within 24 hours for 7 or more days.

 

Results: Breast volume was unchanged between 3 and 6 months. Seventy-one of the treated women were compliant with Brava wear and had a mean augmentation volume at 12 months of 233 ml per breast compared with 134 ml per breast in published series without Brava. Graft survival was 82 ± 18 percent compared with 55 ± 18 percent without Brava.

 

Conclusion: The addition of Brava expansion before autologous fat grafting leads to significantly larger breast augmentations, with more fat graft placement, higher graft survival rates, and minimal graft necrosis or complications, demonstrating high safety and efficacy for the procedure.

 

 

Article by
San Diego Plastic Surgeon